![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 12, 10182-10188, March 21, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Endocrinology and Reproduction Research Branch,
NICHD, National Institutes of Health,
Bethesda, Maryland 20892-4510
Purinergic receptors (P2XRs) activate and
desensitize in response to the binding of extracellular nucleotides in
a receptor- and ligand-specific manner, but the structural bases of
their ligand preferences and channel kinetics have been incompletely characterized. Here we tested the hypothesis that affinity of agonists
for binding domain accounts for a ligand-specific desensitization pattern. We generated chimeras using receptors with variable
sensitivity to ATP in order: P2X4R > P2X2aR = P2X2bR
P2X7R.
Chimeras having the ectodomain Ile66-Tyr310
sequence of P2X2R and Val61-Phe313
sequence of P2X7R in the backbone of P2X4R were
expressed but were non-functioning channels. P2X2a + X4R and P2X2b + X4R chimeras having
the Val66-Tyr315 ectodomain sequence of
P2X4R in the backbones of P2X2aR and
P2X2bR were functional and exhibited increased sensitivity
to ligands as compared with both parental receptors. These chimeras
also desensitized faster than parental receptors and in a
ligand-nonspecific manner. However, like parental P2X2bR
and P2X2aR, chimeric P2X2b + X4R
desensitized more rapidly than P2X2a + X4R, and
the rate of desensitization of P2X2a+X4R
increased by substituting its Arg371-Pro376
intracellular C-terminal sequence with the
Glu376-Gly381 sequence of P2X4R.
These results indicate the relevance of interaction between the
ectodomain and flanking regions around the transmembrane domains on
ligand potency and receptor activation. Furthermore, the ligand potency
positively correlates with the rate of receptor desensitization but
does not affect the C-terminal-specific pattern of desensitization.
To whom correspondence should be addressed: SCS/ERRB/NICHD, Bldg.
49, Rm. 6A-36, 49 Convent Dr., Bethesda, MD 20892-4510. Tel.:
301-496-1638; Fax: 301-594-7031; E-mail: stankos@helix.nih.gov.
This article has been cited by other articles:
![]() |
S. S. STOJILKOVIC, M. TOMIC, M.-L. HE, Z. YAN, T.-A. KOSHIMIZU, and H. ZEMKOVA Molecular Dissection of Purinergic P2X Receptor Channels Ann. N.Y. Acad. Sci., June 1, 2005; 1048(1): 116 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yan, Z. Liang, M. Tomic, T. Obsil, and S. S. Stojilkovic Molecular Determinants of the Agonist Binding Domain of a P2X Receptor Channel Mol. Pharmacol., April 1, 2005; 67(4): 1078 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fabbretti, E. Sokolova, L. Masten, M. D'Arco, A. Fabbro, A. Nistri, and R. Giniatullin Identification of Negative Residues in the P2X3 ATP Receptor Ectodomain as Structural Determinants for Desensitization and the Ca2+-sensing Modulatory Sites J. Biol. Chem., December 17, 2004; 279(51): 53109 - 53115. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rettinger and G. Schmalzing Desensitization Masks Nanomolar Potency of ATP for the P2X1 Receptor J. Biol. Chem., February 20, 2004; 279(8): 6426 - 6433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. He, H. Zemkova, T.-a. Koshimizu, M. Tomic, and S. S. Stojilkovic Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels Am J Physiol Cell Physiol, August 1, 2003; 285(2): C467 - C479. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |